Evidence map›Paper›PMID 37260546›Full record

ArticleInternational journal of chronic obstructive pulmonary disease2023

Are We Missing the Opportunity to Disseminate GOLD Recommendations Through AECOPD Discharge Letters?

Andrea Vukić Dugac, Mirna Vergles, Sanda Škrinjarić Cincar, Ljiljana Bulat Kardum, Marina Lampalo, Sanja Popović-Grle, Jelena Ostojić, Tatjana Tokić Vuksan-Ćusa, Žarko Vrbica, Emilija Lozo Vukovac and 1 more

Open access · goldAbstract read
In one paragraph

Article in International journal of chronic obstructive pulmonary disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 1 country.

Andrea Vukić DugacClinic for Respiratory Diseases, University Hospital Centre Zagreb, Zagreb, Croatia.ORCID 0000-0002-1522-3325
Mirna VerglesDepartment of Pulmonology, Clinical Hospital Dubrava, Zagreb, Croatia.
Sanda Škrinjarić CincarFaculty of Medicine, University of Osijek, Osijek, Croatia.ORCID 0000-0003-2353-0656
Ljiljana Bulat KardumDepartment of Pulmonology, Clinical Hospital Centre Rijeka, Rijeka, Croatia.
Marina LampaloClinic for Respiratory Diseases, University Hospital Centre Zagreb, Zagreb, Croatia.ORCID 0000-0001-9264-6922
Sanja Popović-GrleClinic for Respiratory Diseases, University Hospital Centre Zagreb, Zagreb, Croatia.ORCID 0000-0003-2513-9079
Jelena OstojićPulmonary Outpatient Clinic, Special Hospital for Pulmonary Diseases, Zagreb, Croatia.ORCID 0000-0002-0314-331X
Tatjana Tokić Vuksan-ĆusaDepartment of Internal Medicine, Karlovac General Hospital, Karlovac, Croatia.ORCID 0009-0005-8221-1067
Žarko VrbicaDepartment of Internal Medicine, Dubrovnik General Hospital, Dubrovnik, Croatia.ORCID 0000-0002-2208-7149
Emilija Lozo VukovacDepartment of Pulmonology, University Hospital Split, Split, Croatia.ORCID 0000-0001-6271-4103
Neven TudorićPulmonary Outpatient Clinic, St. Catherine Specialty Hospital, Zagreb, Croatia.ORCID 0000-0001-5170-8074
University Hospital Centre Zagreb · HRKarlovac University of Applied Sciences · HRUniversity Hospital Dubrava · HRUniversity of Dubrovnik · HRUniversity of Osijek · HRUniversity of Split · HR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Acute exacerbations in chronic obstructive pulmonary disease (AECOPD) lead to poor outcomes and increased burden for patients and healthcare systems. The Global Initiative for COPD (GOLD) includes specific recommendations for AECOPD interventions, discharge criteria, and follow-up. Aligning the AECOPD discharge letters (DL) with GOLD guidelines could facilitate dissemination of recommendations among general practitioners (GPs). Purpose: This study was conducted to assess the compliance of DL with the GOLD recommendations in Croatia. Methods: Pre-pandemic DL of patients presenting for AECOPD to emergency room (ER) were analyzed and stratified by clinical decision to hospitalize (HDL) or discharge patients for outpatient treatment (ERDL). Experienced pulmonologists checked the information from DL against guidelines by using online study-specific questionnaires. Results: In total, 225 HDL and 368 ERDL were analyzed. In most cases, the GOLD ABCD categories (85% HDL, 92% ERDL) or the spirometry-based degree of severity (90% HDL, 91% ERDL) were not included. The number of AEs in the previous year was recorded, but the specific frequent exacerbator phenotype not explicitly stated. The AE phenotype was included in two thirds of HDL and one third of ERDL. The blood eosinophil count was frequently available, but not considered decision-relevant information. Adjustments of previous maintenance therapy, mostly escalation, were recommended in 58.4% HDL and 27.9% ERDL, respectively. Education on proper use of inhalers was recommended only in 15.6% of HDL. Smoking cessation measures were advised in 23.1% HDL and 7.9% ERDL; pulmonary rehabilitation in 35.6% HDL and 0.8% ERDL. Early follow-up was frequently advised (>50%), but rarely appointed. Conclusion: Significant deficiencies in compliance with the GOLD guidelines were identified, translating into a missed opportunity for GPs to become acquainted with GOLD recommendations. These findings emphasize the necessity to increase compliance with guidelines first at specialist level and consequent standardization of DL.

Indexed as

Pulmonary Disease, Chronic ObstructiveSmoking CessationDisease ProgressionHumansPatient CompliancePatient DischargeSpirometryacute exacerbationCOPDdischarge recordGOLD guidelines

Identifiers

PMID37260546
PMCPMC10228528
OpenAlexW4378187128

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.